Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Granules in Pediatric Liver or Kidney Transplant Recipients (China)
CTR20212678Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2021
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in graft rejection, sponsored by Astellas Pharma. Started Nov 2021; status: completed.
02
Drugs
tacrolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on CTR20212678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212678.